Ligand
LGND
Ligand (LGND) news
Recent news
Ligand Pharmaceuticals Incorporated - 2026 adj EPS guidance $9 to $9.50, previously $8.50 to $9.50
AInvest Wire · Aug 6, 2026Ligand Pharmaceuticals Incorporated - 2026 total revenue guidance $270 mln to $310 mln
AInvest Wire · Aug 6, 2026LGND sees FY adj EPS $9.00 to $9.50, saw $8.50 to $9.50
AInvest Wire · Aug 6, 2026LGND still sees FY total revenue $270M to $310M, estimated $286.5M
AInvest Wire · Aug 6, 2026Ligand raises low end of '26 adj EPS guidance
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.